YE WEIGUO (Chief Operating Officer) sold 0.4% of their position (2.80K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0001140361-26-025208
Officer· Chief Operating Officer
Since Oct 2023
-2.80K
Net shares
Net seller
$17.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.80K acquired · 5.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.80K
Price / share
$0.75
Trade value
$2.10K
% of position
0.4%
6/11/2026
700K→702.80K
Common Stock
Direct
Shares
−2.80K
Price / share
$6.17
Trade value
$17.28K
% of position
0.4%
6/11/2026
702.80K→700K
Total
Net shares
+0.00
Net value
-$15.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | M · Option Exercise | +2.80K | $0.75 | $2.10K | 0.4% | 700K | 702.80K |
| Common Stock Direct | 6/11/2026 | S · Sale | −2.80K | $6.17 | $17.28K | 0.4% | 702.80K | 700K |
| Total | +0.00 | -$15.18K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.80K shares
Shares
−2.80K
Strike price
0.75
Held after
838.70K
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.80K shares | 6/11/2026 | M · Option Exercise | −2.80K | 0.75 | — | 838.70K |